Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Applying to Emory University Hospital · Atlanta, Georgia
Answer a few short questions to share with the research team.